David Kirn - 02 May 2023 Form 4 Insider Report for 4D Molecular Therapeutics, Inc. (FDMT)

Role
Chief Executive Officer, Director
Signature
/s/ August J. Moretti, Attorney-in-Fact for David Kirn
Issuer symbol
FDMT
Transactions as of
02 May 2023
Transactions value $
$0
Form type
4
Filing time
04 May 2023, 20:09:22 UTC
Previous filing
23 Feb 2023
Next filing
13 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FDMT Common Stock Gift $0 -600K -32.27% $0.00 1.26M 02 May 2023 Direct
transaction FDMT Common Stock Gift $0 +600K $0.00 600K 02 May 2023 Family Trusts F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects gifts of shares by the Reporting Person to irrevocable trusts established for the benefit of the Reporting Person's children. The Goldman Sachs Trust Company of Delaware is the Trustee of such trusts.